| Literature DB >> 35409947 |
Qiying Ding1, Shoufu Lin2, Shanyong Wang3.
Abstract
Currently, coronavirus disease 2019 (COVID-19) is spreading globally, which poses great challenges to the whole world and human beings. The aim of this research is to understand the determinants and residents' willingness to pay (WTP) for purchasing masks against COVID-19 in China. On the basis of protection motivation theory and contingent value method, this research shows that most residents are willing to purchase masks against COVID-19. COVID-19 knowledge, perceived severity, perceived vulnerability, and response efficacy are positively and significantly associated with residents' WTP and the WTP value. However, self-efficacy is only significantly associated with residents' WTP while not with WTP value. Furthermore, compared with other residents, residents in Hubei province have a higher level of COVID-19 knowledge, perceived severity, perceived vulnerability, self-efficacy and response efficacy, and the WTP value is higher. The average value of residents' WTP value for purchasing masks against COVID-19 in Hubei province is ¥120.92 ($18.73) per month during the epidemic, while it is ¥100.16 ($15.50) for other residents. In addition, the effects of demographic factors such as age, gender, income, etc., on residents' WTP and WTP value have also been examined.Entities:
Keywords: COVID-19; contingent value method; mask; protection motivation theory; willingness to pay
Mesh:
Year: 2022 PMID: 35409947 PMCID: PMC8999056 DOI: 10.3390/ijerph19074268
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Reliability and validity analysis.
| Variables | Item | Loading | Cronbach’s Alpha | CR | AVE |
|---|---|---|---|---|---|
| Knowledge | KN1 | 0.85 *** | 0.80 | 0.89 | 0.68 |
| KN2 | 0.77 *** | ||||
| KN3 | 0.84 *** | ||||
| KN4 | 0.83 *** | ||||
| Perceived severity | PS1 | 0.88 *** | 0.82 | 0.88 | 0.71 |
| PS2 | 0.83 *** | ||||
| PS3 | 0.81 *** | ||||
| Perceived vulnerability | PV1 | 0.79 *** | 0.77 | 0.84 | 0.64 |
| PV2 | 0.82 *** | ||||
| PV3 | 0.79 *** | ||||
| Self-efficacy | SE1 | 0.79 *** | 0.83 | 0.89 | 0.72 |
| SE2 | 0.89 *** | ||||
| SE3 | 0.87 *** | ||||
| Response efficacy | RE1 | 0.81 *** | 0.79 | 0.86 | 0.67 |
| RE2 | 0.79 *** | ||||
| RE3 | 0.86 *** |
Note: *** indicates significant at 0.1% significance level.
Discriminant validity analysis.
| Variables | KN | PS | PV | SE | RE |
|---|---|---|---|---|---|
| KN |
| 0.42 | 0.63 | 0.57 | 0.49 |
| PS | 0.53 |
| 0.37 | 0.53 | 0.38 |
| PV | 0.48 | 0.35 |
| 0.49 | 0.51 |
| SE | 0.55 | 0.43 | 0.43 |
| 0.50 |
| RE | 0.41 | 0.45 | 0.38 | 0.33 |
|
Note: The bold values (diagonal elements) are the square root of AVE values; the values below the diagonal are the correlation coefficients among variables; the values above the diagonal are the Heterotrait–Monotrait (HTMT) Ratio of each variable.
Samples’ demographic information.
| Category | Total Sample | Non-Hubei Sample | Hubei Sample | ||||
|---|---|---|---|---|---|---|---|
|
| % |
| % |
| % | ||
| Gender | Female | 1701 | 54.03% | 1093 | 53.45% | 582 | 52.77% |
| Male | 1447 | 45.97% | 952 | 46.55% | 521 | 47.23% | |
| Age | 18–25 | 564 | 17.92% | 350 | 17.11% | 190 | 17.23% |
| 26–40 | 723 | 22.97% | 481 | 23.52% | 250 | 22.67% | |
| 41–50 | 941 | 29.89% | 623 | 30.46% | 330 | 29.92% | |
| 51–60 | 503 | 15.98% | 318 | 15.55% | 173 | 15.68% | |
| >60 | 417 | 13.25% | 273 | 13.35% | 160 | 14.51% | |
| Years of education | ≤6 | 314 | 9.97% | 218 | 10.66% | 121 | 10.97% |
| 7–9 | 316 | 10.04% | 181 | 8.85% | 120 | 10.88% | |
| 10–12 | 789 | 25.06% | 519 | 25.38% | 271 | 24.57% | |
| 13–16 | 1045 | 33.20% | 691 | 33.79% | 369 | 33.45% | |
| ≥17 | 684 | 21.73% | 436 | 21.32% | 222 | 20.13% | |
| Monthly Income | <¥5000 ($774) | 409 | 12.99% | 251 | 12.27% | 162 | 14.69% |
| ¥5000–10,000 ($1548) | 1101 | 34.97% | 731 | 35.75% | 381 | 34.54% | |
| ¥10,001–15,000 ($2322) | 1070 | 33.99% | 701 | 34.28% | 362 | 32.82% | |
| >¥15,000 | 568 | 18.04% | 362 | 17.70% | 198 | 17.95% | |
| Family size | 1 | 220 | 6.99% | 139 | 6.80% | 75 | 6.80% |
| 2–3 | 1448 | 46.00% | 921 | 45.04% | 516 | 46.78% | |
| 4–5 | 1196 | 37.99% | 775 | 37.90% | 408 | 36.99% | |
| >5 | 284 | 9.02% | 210 | 10.27% | 104 | 9.43% | |
| Health status | Not well | 1045 | 33.20% | 690 | 33.74% | 370 | 33.54% |
| Acceptable | 1479 | 46.98% | 952 | 46.55% | 501 | 45.42% | |
| Very well | 624 | 19.82% | 403 | 19.71% | 232 | 21.03% | |
| Observations | 3148 | 2045 | 1103 | ||||
Descriptive analysis result of research variable.
| Variables | Total Sample | Non-Hubei Sample | Hubei Sample | |||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | |
| Knowledge (KN) | 3.639 | 0.518 | 3.501 | 0.683 | 3.973 | 0.732 |
| Perceived severity (PS) | 4.219 | 0.457 | 4.093 | 0.683 | 4.472 | 0.702 |
| Perceived vulnerability (PV) | 4.313 | 0.537 | 4.101 | 0.781 | 4.598 | 0.692 |
| Self-efficacy (SE) | 4.411 | 0.531 | 4.278 | 0.602 | 4.693 | 0.573 |
| Response efficacy (RE) | 4.298 | 0.633 | 4.128 | 0.821 | 4.601 | 0.721 |
Note: SD = Standard Deviation.
Residents’ WTP.
| Response | Total Sample | Non-Hubei Sample | Hubei Sample | |||
|---|---|---|---|---|---|---|
| Frequency | Ratio | Frequency | Ratio | Frequency | Ratio | |
| Willing to pay | 2581 | 81.99% | 1635 | 79.95% | 993 | 90.03% |
| Unwilling to pay | 567 | 18.01% | 410 | 20.05% | 110 | 9.97% |
| Observations | 3148 | 2045 | 1103 | |||
Reasons of unwilling to pay.
| Reason | Total Sample | Non-Hubei Sample | Hubei Sample | |||
|---|---|---|---|---|---|---|
| Frequency | Ratio | Frequency | Ratio | Frequency | Ratio | |
| I am healthy and have strong immunity | 210 | 37.04% | 140 | 34.15% | 52 | 47.27% |
| I always stay at home | 165 | 29.10% | 120 | 29.27% | 31 | 28.18% |
| COVID-19 will end soon | 80 | 14.11% | 50 | 12.20% | 20 | 18.18% |
| I have no money | 32 | 5.64% | 25 | 6.10% | 1 | 0.91% |
| The cost should be paid by the government | 80 | 14.11% | 75 | 18.29% | 6 | 5.45% |
| Observations | 567 | 410 | 110 | |||
Determinants of residents’ WTP.
| Variables | Logistic Regression | ||
|---|---|---|---|
| Total Sample | Non-Hubei Sample | Hubei Sample | |
| Model 1 | Model 2 | Model 3 | |
| Knowledge | 0.345 * | 0.281 ** | 0.389 ** |
| Perceived severity | 0.465 *** | 0.412 * | 0.507 *** |
| Perceived vulnerability | 0.321 * | 0.318 ** | 0.397 * |
| Self-efficacy | 0.238 ** | 0.221 * | 0.313 * |
| Response efficacy | 0.317 * | 0.291 *** | 0.403 *** |
| Gender | −0.131 ** | −0.187 ** | 0.149 |
| Age | 0.131 | 0.123 | 0.199 |
| Education | 0.204 | 0.253 | 0.101 |
| Income | 0.181 | 0.153 | 0.271 |
| Family size | 0.208 * | 0.196 ** | 0.314 |
| Health status | 0.217 | 0.253 | 0.318 |
| Observations | 3148 | 2045 | 1103 |
| LR χ2 | 130.218 | 123.679 | 141.783 |
| Prob > χ2 | 0.000 | 0.000 | 0.001 |
| Pseudo R2 | 0.554 | 0.511 | 0.589 |
| Log Likelihood | −269.341 | −291.327 | −245.827 |
Notes: * <0.05, ** <0.01 and *** <0.001.
Relative importance weights of the determinants of residents’ WTP.
| Variables | Raw Relative Weight | Rescaled Relative Weight |
|---|---|---|
| Knowledge | 0.091 | 16.49% |
| Perceived severity | 0.113 | 20.49% |
| Perceived vulnerability | 0.081 | 14.77% |
| Self-efficacy | 0.061 | 11.02% |
| Response efficacy | 0.054 | 9.56% |
| Gender | 0.018 | 3.18% |
| Age | 0.026 | 4.74% |
| Education | 0.028 | 5.11% |
| Income | 0.024 | 4.18% |
| Family size | 0.025 | 4.46% |
| Health status | 0.033 | 6.01% |
| Pseudo R2 | 0.554 | 100% |
Distribution of residents’ WTP value.
| Interval | Total Sample | Non-Hubei Sample | Hubei Sample | |||
|---|---|---|---|---|---|---|
| Frequency | Ratio | Frequency | Ratio | Frequency | Ratio | |
| ¥1–30 | 288 | 11.16% | 225 | 13.76% | 70 | 7.05% |
| ¥31–60 | 422 | 16.35% | 345 | 21.10% | 70 | 7.05% |
| ¥61–90 | 255 | 9.88% | 195 | 11.93% | 55 | 5.54% |
| ¥91–120 | 481 | 18.64% | 245 | 14.98% | 260 | 26.18% |
| ¥121–150 | 592 | 22.94% | 299 | 18.29% | 300 | 30.21% |
| ¥151–180 | 241 | 9.34% | 91 | 5.57% | 130 | 13.09% |
| ¥181–210 | 187 | 7.25% | 125 | 7.65% | 60 | 6.04% |
| ¥211–240 | 115 | 4.46% | 110 | 6.73% | 48 | 4.83% |
| Observations | 2581 | 1635 | 993 | |||
Determinants of residents’ WTP value.
| Variables | Total Sample | Non-Hubei Sample | Hubei Sample |
|---|---|---|---|
| Model 4 | Model 5 | Model 6 | |
| Knowledge | 0.221 * | 0.309 *** | 0.268 ** |
| Perceived severity | 0.263 * | 0.197 ** | 0.331 *** |
| Perceived vulnerability | 0.280 ** | 0.251 ** | 0.342 * |
| Self-efficacy | 0.347 | 0.202 | 0.307 |
| Response efficacy | 0.401 *** | 0.344 ** | 0.413 *** |
| Gender | −0.181 ** | −0.197 * | −0.287 |
| Age | −0.207 | −0.183 | −0.257 |
| Education | 0.231 | 0.253 | 0.186 |
| Income | 0.136 | 0.187 | 0.256 |
| Family size | −0.260 | −0.183 | 0.259 |
| Health status | −0.237 * | −0.209 ** | −0.289 |
| Observations | 2581 | 1635 | 993 |
| Wald χ2 | 97.359 | 92.257 | 89.183 |
| Prob > χ2 | 0.000 | 0.000 | 0.000 |
| Log Likelihood | −1123.387 | −1242.207 | −1037.342 |
Notes: * <0.05, ** <0.01 and *** <0.001.
| Variables | Measurement Item |
|---|---|
| Knowledge (KN) | KN1: COVID-19 is a respiratory infection caused by a new species of coronavirus family |
| KN2: COVID-19 can be transmitted through respiratory droplets such as cough and sneeze | |
| KN3: COVID-19 can be prevented through wearing mask and personal hygiene | |
| KN4: The common symptoms of COVID-19 are fever, cough and shortness of breath | |
| Perceived severity (PS) | PS1: COVID-19 is a serious social issue |
| PS2: COVID-19 will have negative consequences | |
| PS3: The negative effect of COVID-19 is severe | |
| Perceived vulnerability (PV) | PV1: COVID-19 can negatively impact me |
| PV2: I am vulnerable to the negative effects of COVID-19 | |
| PV3: My chances of being infected by COVID-19 is high | |
| Self-efficacy (SE) | SE1: It is easy for me to purchase and wear mask |
| SE2: If I wanted to, I could easily purchase and wear mask | |
| SE3: It is mostly up to me whether I purchase and wear mask | |
| Response efficacy (RE) | RE1: Wearing mask can impede the spread of COVID-19 |
| RE2: Wearing mask can lower the chances of being infected by COVID-19 | |
| RE3: Wearing mask can defeat COVID-19 as soon as possible |